Study follow-up for high-risk HPV in people with gynecologic history
Part of Infections, Women’s health & pregnancy clinical trials.
This study looks at follow-up care for anal (rear passage) HPV risk in adults who previously had high-risk HPV–related gynecologic changes. It aims to better track disease that may be related to HPV and possibly help guide future monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had a high-grade or higher HPV-related gynecologic lesion
- You are already scheduled for a proctology (rear passage) follow-up visit
- You speak French
- You have not previously had a high-grade or higher HPV-related anal lesion
- You are able and willing to let the researchers use your data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying high-resolution anuscopy (a detailed exam of the anal area) in people who are referred for this procedure. It aims to learn more about the findings and help improve care.
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
This study uses a detailed DNA test to look for high-risk HPV in people with long-lasting (chronic) infection after treatment or with return of abnormal cells. It may help improve how clinicians monitor high-risk HPV and decide next steps.
This study looks at HPV (the virus that can cause anal cancer) and checks if certain types of high-risk HPV are linked to abnormal cells or cancer in the anus, 10 years after joining the IPERGAY trial. It helps researchers understand long-term risks.
This study follows people with severe or hard-to-treat HPV-related conditions (and some closely related partners/household contacts) to learn how the virus causes illness and how the immune system responds. It may help doctors better predict who will develop severe disease and guide future treatments.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
Hear when a new Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.